These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38101679)
1. A novel chimeric recombinant FliC-Pgp3 vaccine promotes immunoprotection against Chlamydia muridarum infection in mice. Zhao L; Wang X; Li Z Int J Biol Macromol; 2024 Feb; 258(Pt 1):128723. PubMed ID: 38101679 [TBL] [Abstract][Full Text] [Related]
2. Preparation of graphene oxide-stabilized Pickering emulsion adjuvant for Pgp3 recombinant vaccine and enhanced immunoprotection against Zhao L; Shu M; Chen H; Shi K; Li Z Front Immunol; 2023; 14():1148253. PubMed ID: 37143655 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice. Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842 [TBL] [Abstract][Full Text] [Related]
4. Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice. Mosolygó T; Szabó AM; Balogh EP; Faludi I; Virók DP; Endrész V; Samu A; Krenács T; Burián K Vaccine; 2014 Sep; 32(40):5228-33. PubMed ID: 25077421 [TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987 [TBL] [Abstract][Full Text] [Related]
6. Chlamydia Deficient in Plasmid-Encoded Glycoprotein 3 (pGP3) as an Attenuated Live Oral Vaccine. Zhou Z; Tian Q; Wang L; Zhong G Infect Immun; 2022 Mar; 90(3):e0047221. PubMed ID: 35100010 [TBL] [Abstract][Full Text] [Related]
7. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice. Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151 [TBL] [Abstract][Full Text] [Related]
8. Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice. Liu Y; Huang Y; Yang Z; Sun Y; Gong S; Hou S; Chen C; Li Z; Liu Q; Wu Y; Baseman J; Zhong G Infect Immun; 2014 Dec; 82(12):5327-35. PubMed ID: 25287930 [TBL] [Abstract][Full Text] [Related]
9. The Structural Integrity of Plasmid-Encoded Pgp3 Is Essential for Induction of Hydrosalpinx by Huang Y; Sun Y; Qin T; Liu Y Front Cell Infect Microbiol; 2019; 9():13. PubMed ID: 30805313 [TBL] [Abstract][Full Text] [Related]
10. The Genital Tract Virulence Factor pGP3 Is Essential for Chlamydia muridarum Colonization in the Gastrointestinal Tract. Shao L; Zhang T; Melero J; Huang Y; Liu Y; Liu Q; He C; Nelson DE; Zhong G Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038127 [TBL] [Abstract][Full Text] [Related]
11. Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice. Shu M; Zhao L; Shi K; Lei W; Yang Y; Li Z Front Immunol; 2022; 13():989620. PubMed ID: 36505424 [TBL] [Abstract][Full Text] [Related]
12. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology. Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133 [TBL] [Abstract][Full Text] [Related]
14. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. Andrew DW; Cochrane M; Schripsema JH; Ramsey KH; Dando SJ; O'Meara CP; Timms P; Beagley KW PLoS One; 2013; 8(9):e76664. PubMed ID: 24073293 [TBL] [Abstract][Full Text] [Related]
15. The Plasmid-Encoded pGP3 Promotes Zhang T; Huo Z; Ma J; He C; Zhong G Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30858342 [TBL] [Abstract][Full Text] [Related]
16. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608 [TBL] [Abstract][Full Text] [Related]
17. Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Sahu R; Dixit S; Verma R; Duncan SA; Smith L; Giambartolomei GH; Singh SR; Dennis VA Front Immunol; 2021; 12():660932. PubMed ID: 33936096 [TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice. Manam S; Chaganty BK; Evani SJ; Zafiratos MT; Ramasubramanian AK; Arulanandam BP; Murthy AK PLoS One; 2013; 8(5):e64917. PubMed ID: 23741420 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection. Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]